FDA approves Pharmaxis' Aridol

FDA approved an NDA from Pharmaxis Ltd. (ASX:PXS; Pink:PXSLY) for Aridol Bronchial Challenge Test Kit to assess bronchial hyperresponsiveness in patients six or older who do not have clinically appare...